Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Cytokinetics Inc

Cytokinetics Inc (CYTK)

Market is closed
News
Is Cytokinetics, Incorporated (CYTK) A Good Stock To Buy?

Is Cytokinetics, Incorporated (CYTK) A Good Stock To Buy?

We at Insider Monkey have gone over 752 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...

Keep Reading →

December 10th, 2019 - Hedge Funds News

Here is What Hedge Funds Really Think About Cytokinetics, Incorporated (CYTK)

Here is What Hedge Funds Really Think About Cytokinetics, Incorporated (CYTK)

We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.

Keep Reading →

November 1st, 2019 - Hedge Funds News

Hedge Fund and Insider Trading News: Michael Platt, Warren Buffett, Balyasny Asset Management, AQR Capital, Aspen Group Inc (ASPU), W&T Offshore, Inc. (WTI), and More

Hedge Fund and Insider Trading News: Michael Platt, Warren Buffett, Balyasny Asset Management, AQR Capital, Aspen Group Inc (ASPU), W&T Offshore, Inc. (WTI), and More

BOSTON (Reuters) - Balyasny Asset Management, a Chicago-based hedge fund that shed $4 billion in assets last year and cut 20% of its staff, was back in positive territory for the first half of this year...

Keep Reading →

July 15th, 2019 - Hedge Funds Insider Trading

Did Hedge Funds Drop The Ball On Cytokinetics, Inc. (CYTK) ?

Did Hedge Funds Drop The Ball On Cytokinetics, Inc. (CYTK) ?

Hedge fund interest in Cytokinetics, Inc. (NASDAQ:CYTK) shares was flat at the end of last quarter and it wasn't that high to begin with. This is usually a negative indicator.

Keep Reading →

June 27th, 2019 - Hedge Funds News

Hedge Funds Are Dumping Cytokinetics, Inc. (CYTK)

Hedge Funds Are Dumping Cytokinetics, Inc. (CYTK)

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.

Keep Reading →

December 22nd, 2018 - Hedge Funds News

13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)

13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)

Cytokinetics Inc (NASDAQ:CYTK): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP's latest holdings and filings here.

Keep Reading →

December 1st, 2017 - Hedge Funds

13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)

13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)

You can access the original SEC filing by clicking here.

Keep Reading →

May 15th, 2017 - Hedge Funds

Here's What You Should Know About The Finance World Today

Here's What You Should Know About The Finance World Today

"U.S. stocks retreated on Tuesday as a spate of tepid corporate earnings weighed on the broader market.

Keep Reading →

April 18th, 2017 - Commodities Gold Market Movers News Tech

Cytokinetics, Inc. (CYTK) Hedge Funds Are Snapping Up

Cytokinetics, Inc. (CYTK) Hedge Funds Are Snapping Up

Looking for high-potential stocks? Just follow the big players within the hedge fund industry.

Keep Reading →

December 9th, 2016 - Hedge Funds News

Cytokinetics Inc (CYTK): Mark Lampert's Biotechnology Value Fund Loads Up On More Shares

Cytokinetics Inc (CYTK): Mark Lampert's Biotechnology Value Fund Loads Up On More Shares

Mark Lampert's Biotechnology Value Fund has filed a Form 13G on Cytokinetics, Inc. (NASDAQ:CYTK), one of its top-10 holdings at the end of 2015.

Keep Reading →

March 6th, 2016 - Hedge Funds News

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)